⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONCY News
Oncolytics Biotech, Inc. Common Shares
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
prnewswire.com
ONCY
NRIX
ERAS
FHTX
ORIC
The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era
globenewswire.com
ONCY
IBRX
BNTX
CMPX
THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points
globenewswire.com
ONCY
VWAV
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
globenewswire.com
ONCY
CGON
TAK
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
prnewswire.com
ONCY
CGON
ZNTL
AVBP
PDSB
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
globenewswire.com
ONCY
ALLO
CHRS
PYXS
ELVN
Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer
globenewswire.com
ONCY
Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada
globenewswire.com
ONCY
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
globenewswire.com
ONCY
SLS
CELC
RNXT
THE CHOKE POINT: 5 Assets That Control the Bottleneck
globenewswire.com
ONCY
VWAV